ETACHMENT desquamation and dystrophy of endothelial cells 22, 39 and necrotic changes in the SMCs of the tunica media 13 are the most striking histological alterations involving large and penetrating arteries 52 following SAH. There is evidence that oxyhemoglobin produces direct cytotoxicity in SMCs and endothelial cells and induces cell death via either apoptotic or necrotic pathways at the final stage of cell damage.
sis are prominent in the tunica media, whereas important changes in endothelial cells include apoptosis. 30, 31 Our aims in the present study were first to explore changes in SMC cytoskeletal and contractile proteins and extracellular collagen in rabbit BAs after SAH and second to assess the preventive capacity of an established antiinflammatory agent on these changes. Glucocorticoids could be favorable in the course of SAH because of their antiinflammatory actions, their proteinase inhibitor effects, their action on smooth-muscle contraction, and some of their antianabolic effects. High doses of corticosteroids have been used in attempts to prevent vasospasm and improve outcome in experimental and clinical studies with some positive results. 9, 10, 20 We thus used a laser-scanning confocal microscope to measure the immunohistochemical staining density of the ␣-actin filaments, the actin-binding protein h-caldesmon, the intermediate filament vimentin, smoothelin-B, a recently discovered cytoskeletal protein supposed to be a marker of SMC differentiation, 42, 43 and type I collagen. Having established the modifications present 7 days post-SAH, we tested the therapeutic effects of high-dose dexamethasone in a second series.
Materials and Methods
Experiments were conducted in compliance with the guidelines for animal experimentation in the Centre National de la Recherche Scientifique. Fauve de Bourgogne rabbits (five animals/group) each weighing between 2.5 and 3.2 kg were included in the study. The study was performed in two phases to maintain the maximum comparability between groups for the immunohistochemical analysis. The first comparison was made between a control (sham-injured group; Group I) and an SAH group (Group II). The second comparison was between a second SAH group (Group III) and an SAHdexa group (Group IV).
All rabbits were premedicated with acepromazine (1 mg/kg given intravenously) and deeply anesthetized with intravenously administered ethomidate (0.6 mg/kg) and pentobarbital (15 mg/kg). In each group, under sterile conditions the cisterna magna received either physiological solution (Group I) or autologous arterial blood (Groups II-IV) on Day 0. For the SAH groups, fresh autologous nonheparinized arterial whole blood (0.3-0.9 ml) was withdrawn from the central ear artery and injected slowly (30-90 seconds) into the cisterna magna; the total dose injected over a 30-to 60-minute period was 0.8 to 1 ml/kg body weight. 16, 44 The control group received physiological solution in the same manner. After injection, the animals were tilted in a head-down position for 5 minutes. In the SAH groups (Groups II-IV), the recovery time was often delayed but without any evident focal neurological deficiency. The animals in Group IV were treated with an intramuscular injection of dexamethasone (Qualimed Laboratories, Merck Generics, Lyon, France, 5.6 mg/kg each time) immediately after the induction of SAH and at 24 and 48 hours post-SAH.
Immunohistochemical Study
On Day 7, pentobarbital was used to induce anesthesia, the animals were killed, and their brains were removed and placed in 0.1 M PBS at pH 7.4 (NaCl 120 mM, KCl 2.7 mM in a 10-mM phosphate buffer). The BA was cleaned of arachnoid membrane and blood (nine animals had a residual clot) and immediately frozen in an embedding medium (Tissue-Tek; Miles, Inc., Elkhart, IN) cooled in isopentane to Ϫ50˚C. The anterior half of the BA (the site where the clot was most persistent) was cut into 20-m-thick sections by using a freezing microtome (CM 3050S; Leica Microsystèmes SAS, Rueill-Malmaison, France), mounted on slides, and processed for immunohistochemical examination. Sections from Groups I and II (first comparison) or Groups III and IV (second comparison) were collected on the same glass slides, which allowed simultaneous immunofluorescence processing and comparisons. All sections on each slide were processed using the same antigen. Sections for vimentin immunostaining were fixed with 100% ethanol for 30 minutes at 4˚C. Sections for ␣-actin, h-caldesmon, smoothelin-B, and type I collagen immunostaining were fixed with 2% paraformaldehyde in PBS for 30 minutes at 4˚C. Sections were permeabilized with PBS containing 1% Triton X-100 at 4˚C for 10 minutes and, after rinsing, were incubated in 0.5% bovine serum albumin in PBS at 4˚C before being exposed to the primary antibody for 1 hour at 4˚C in a dark, humid chamber. After an additional rinsing, the sections were incubated in darkness at 4˚C for 1 hour with the secondary antibody, fluorescein isothiocyanate-conjugated goat anti-mouse IgG (F-8264; Sigma Chemical Co., St. Louis, MO), diluted 1:100, and mounted in a medium containing Mowiol (Calbiochem, La Jolla, CA).
The primary antibodies, which were diluted with PBS containing
Confocal images demonstrating immunofluorescence staining of the examined proteins in a control rabbit BA. The image depicts ␣-actin, h-caldesmon, and smoothelin-B in the media (a-c). Vimentin is localized in both the media and the adventitia (d), and type I collagen is localized mostly in the adventitia but also in small bundles in the media (e). Immunostaining of collagen is expressed in abundance also among the elastic fibers of the internal lamina. Original magnification ϫ 40 (bar = 100 m). 
Confocal Microscopy
The fluorescence-labeled sections were examined using a confocal laser-scanning microscope (MRC 600; Bio-Rad Microscience, Hertfordshire, UK) attached to an Optiphot microscope (Nikon; Tokyo, Japan). Images were acquired using a single excitation at 488 nm for fluorescein isothiocyanate labeling. After we had determined the focal plane of the upper surface of the 20-m-section (depth 0 m), a series of three-planar images were collected at depths of 8, 10, and 12 m. Then, the three individual tomographic images of each section were summed according to the maximum pixel summation method for projection on the video screen and analysis. All artery sections were scanned at an optical magnification of 40 with identical settings for all images obtained from the same slide. For all antigens tested, measurements were performed in the medial layer of the BA, except for type I collagen, which was measured both in the medial and adventitial layers and these measurements were reported separately. The software displayed the histogram of pixel intensity expressed as 256 gray levels (or intensity levels) from 0 to 255. The intensity of immunostaining (scale 0-255) for a given protein can be considered proportional to the quantity of protein antigens recognized in the chosen area. Within the whole contour of the artery on the video screen, we delimited as many rectangles measuring 20 ϫ 15 m (area 300 m 2 ) as possible to measure within the entire defined zone the mean pixel value for the immunofluorescent labeling. This gave us a measure of the mean antigen density, ranging from 0 (no fluorescence) to 255 (maximum fluorescence), independently of the overall area or volume of the histological sample. For ␣-actin, vimentin, h-caldesmon, and smoothelin-B the zone was limited to the media; for type I collagen we measured either within the media or the adventitia. All available data for each rabbit, that is, data from all sections treated for a given antigen, were pooled to obtain an average value per rabbit for analysis and were expressed as means Ϯ SDs. The differences between groups were assessed by performing a Student t-test. A probability value less than 0.05 was considered significant.
Results
The rabbit BA was immunohistochemically stained for the four SMC protein markers: ␣-actin, vimentin, h-caldesmon, and smoothelin-B. Both ␣-actin and h-caldesmon ( Fig. 1a and b) were widely expressed in the media, whereas a small proportion of cells in the media appeared to lack any smoothelin-B and vimentin ( Fig. 1c and d) . Endothelial and adventitial cells displayed a positive reaction for vimentin, and type I collagen was distributed densely in the adventitia and sparsely in the media (Fig. 1e) . All markers displayed a homogeneous staining distribution along the portion of the BA that was examined (data not shown).
Modifications of Protein Densities by SAH
Compared with the control group (Group I), the first SAH group (Group II; Table 1 ) demonstrated a significant decrease in the antigen densities of ␣-actin (Ϫ11%, p = 0.01) and adventitial type I collagen (Ϫ45%, p = 0.01) and an almost significant decrease in the antigen density of hcaldesmon (Ϫ15%, p = 0.06) in SAH rabbits on Day 7. On the contrary, there were significant increases in the antigen densities of vimentin (ϩ15%, p = 0.04) and smoothelin-B (ϩ53%, p = 0.04) in the SAH group. The level of the antigen density of type I collagen in the media was not different between the two groups on Day 7.
Preventive Effects of Dexamethasone Post-SAH
Compared with the second SAH group (Group III), the SAH-dexa group (Group IV; Table 2 ) displayed a significant increase in the antigen densities of ␣-actin (ϩ13%, p = 0.05) and h-caldesmon (ϩ20%, p = 0.01) in SAH rabbits treated with dexamethasone. On the contrary, there was a significant decrease in the antigen densities of vimentin (Ϫ55%, p = 0.05) in SAH rabbits treated with dexamethasone. There was no variation in the density of medial and adventitial type I collagen between Groups III and IV (ϩ1% and ϩ1% in each), and there was a nonsignificant increase in smoothelin-B antigen density in the SAH-dexa group. Figure 2 shows values of each antigen density in the SAH and SAH-dexa groups calculated with reference to the values of the control group. The diminution in the antigen densities of ␣-actin and h-caldesmon produced by SAH alone was abolished by the dexamethasone treatment, with levels returning to the reference control values (changes of ϩ0.76 for ␣-actin and ϩ2.53 for h-caldesmon). The augmentation in vimentin density caused by SAH alone was reversed to a level below the reference control values in the SAH-dexa group (difference Ϫ48.5). In contrast, the smoothelin-B density in rabbits subjected to SAH and treated with dexamethasone did not tend toward reference values, but rather to higher values. The densities of type I collagen in the media and adventitia were not significantly modified by the dexamethasone treatment.
Discussion
In this study we found significant or nearly significant changes in the immunoreactivity of four proteins (␣-actin, vimentin, smoothelin-B, and h-caldesmon) and a significant decrease in adventitial, but not medial type I collagen expression in the BAs of animals subjected to SAH when compared with control animals. Dexamethasone treatment reversed these changes in the expression of ␣-actin, vimentin, and h-caldesmon, but not the changes in the expression
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Dexamethasone and artery protein changes post-SAH of smoothelin-B. There was no influence of dexamethasone on the expression of adventitial and medial type I collagen.
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Although some researchers have reported that immunoreactivity against ␣-actin was not altered, 21, 32 other recent studies have shown a decrease in ␣-actin after SAH, which is consistent with the time course of angiographic vasospasm. 16, 22, 26, 41 In this study we confirmed the latter findings by using a quantitative method for measuring immunofluorescence. We also found a nearly significant (p = 0.06) decrease in immunostaining of h-caldesmon in the media of the BAs in the SAH groups. This result conforms with those of other studies, 32, 41 and our SAH model with a delayed time point of measurement (Day 7) confirms the delayed impairment of the contractile apparatus of SMCs.
The number of cultured canine BA SMCs decreased when incubated with oxyhemoglobin. 30, 32 This was associated with an early and prolonged impairment of protein synthesis. 32 The deficiencies of ␣-actin and h-caldesmon may result from increased proteolysis and inhibition of protein synthesis in SMCs and may lead to sustained contraction and loss of these cells' relaxation properties. 44 It has been suggested that calponin and caldesmon are phosphorylated through protein kinase C-dependent pathways, and that these phosphorylations may cause a loss in the ability of calponin and caldemon to relax SMCs. 29 One possible explanation for ␣-actin and h-caldesmon proteolysis is activation of the calpains, which are Ca-dependent cysteine endopeptidases activated by increased intracellular Ca. 8, 45 The hypothesis of a progressive proteolytic mechanism with -calpain after SAH has been extensively developed. This hypothesis is supported by separate reports that vascular smooth muscle contains relatively large amounts of calpain, 23 that smooth-muscle intracellular Ca is elevated in vasospasm, 7, 51 and that calpains are activated in vasospasm. 25, 49 Calpain is reported to initiate nonlysosomal degradation of ␣-actin, desmin, talin, and vimentin. 4, 6, 28, 48, 50 Many mechanisms could be involved in the regulation of calpain activation 8 and most of them could be altered in SAH.
The intermediate filaments of vimentin are well-characterized cytoskeletal elements expressed in all vascular
SMCs of the brain. 37 The principal function of vimentin is to reinforce and provide mechanical support for the cell plasma membrane. Contrasting with actin microfilaments or microtubules, vimentin is extremely stable and seems not to be a preferential substrate for the calpains.
14,27 Macdonald, et al., 21 found no change in the vimentin immunofluorescence intensity in adventitia and media in a monkey model of SAH. Only a slight deposition in proliferated intima was seen. In contrast, the present study shows increased vimentin density in the media on Day 7 post-SAH, confirming our previous findings 16 and indicating late remodeling of the vascular wall after SAH.
Smoothelin-B, a protein of minor abundance specific to vascular SMCs, appears to be a marker of the contractile phenotype. 42, 43, 47 This study is the first in which smoothelin-B expression in experimental SAH was explored, and it demonstrates that smoothelin-B expression was markedly increased 1 week after SAH. This protein may be not a preferential calpain substrate or may be highly resistant to such proteases. The increased expression of smoothelin-B in cerebral arteries found here after SAH could be a cellular response to proteolysis in an attempt to conserve shape, structural integrity, and major function of vascular SMCs. Nevertheless, in our study we evaluated changes in the density of smoothelin-B at a single, late time point (Day 7 post-SAH), and we cannot be sure that these changes are related to vasospasm and artery stiffness. 5 This point awaits further evaluation.
One week after SAH, type I collagen expression remained unchanged in the media of the BAs, whereas it significantly decreased in the adventitia. In a rat femoral artery vasospasm model, Kasuya, et al., 19 showed that expression of type I procollagen mRNA decreased slightly within 3 days after exposure to blood and increased significantly from 7 to 14 days. They also demonstrated that TGF␤ gene expression was stimulated 3 days after exposure to blood, at which time procollagen gene expression remained unchanged. These results indicate a significant time lag between the blood stimulus and the TGF␤ response and the collagen synthesis within the arterial wall as demonstrated in wound repair. 48 Our findings are not at variance with these results and could be explained by the fact that measurements were performed before the increase in procollagen synthesis occurred. It is also likely that the events after exposure of the rat femoral artery to blood do not follow precisely the same evolution as those after injection of blood into the rabbit subarachnoid space.
The reversal of changes in the expression of the three smooth-muscle proteins-␣-actin, h-caldesmon, and vimentin-in response to dexamethasone treatment is consistent with the hypothesis that inflammatory reactions develop in the vascular wall after SAH. Genes encoding for proteins related to inflammatory events have been found to be upregulated in canine, rat, and primate models of vasospastic arteries. 17, 19, 33, 35, 46 The mRNA expression in the rat BA for IL-1␣, IL-6, IL-8, intercellular adhesion molecule-1, and type I collagen are highly elevated in SAH arteries, and cytokine levels fit remarkably well with the time course of vasospasm: the mRNA level of IL-1␣, IL-6, IL-8, and intercellular adhesion molecule-1 is highest on Day 7 but not before Day 14 post-SAH for type I collagen. 1 Glucocorticoid hormones regulate many different biological processes via their specific intracellular receptors, the glucocorticoid receptors, which are present in most cell types. In a previous study corticosteroid and antiinflammatory drugs have shown positive results in inhibiting vasospasm in the canine model 11 but most effects of glucocorticoid agents are speculative in the cases of vasospasm associated with SAH because most of them have been determined from studies based on cultured SMCs or isolated arteries. Glucocorticoids exert their antiinflammatory activity largely by inhibition of nuclear factor B and repression of genes activated by AP-1 transcription factors (for reviews see the articles by Almawi and Melemedjian 2 and McKay and Cidlowski
23
). Glucocorticoids are also known to inhibit proteinases such as calpain. 3, 34 For example, methylprednisolone, prednisolone, and dexamethasone were found to inhibit purified muscle calpain and Ca ϩϩ -requiring proteinase activity in a dose-dependent manner. 3 Prolonged pretreatment with betamethasone impairs calpain activation in the rabbit hippocampus after hypoxia. 34 In our study the preventive effects on ␣-actin and h-caldesmon degradation by dexamethasone may be due to, or at least favored by its calpain-inhibiting property. Nevertheless, our study provides no data on whether dexamethasone influenced protein levels before and during the onset of vasospasm.
It is also established that glucocorticoids have an antianabolic effect on collagen metabolism, 12, 40 and recent studies indicate that glucocorticoids regulate procollagen gene expression though decreased secretion of TGF␤. 18, 24, 36 The present study, however, did not show any difference between the SAH and the dexamethasone-treated SAH groups in BA immunostaining for type I collagen. As explained earlier, the time course of events may be such that we could not see increased collagen expression 7 days after SAH or the downregulation that should be expected with dexamethasone treatment. The short duration of dexamethasone treatment (Days 0-2) may also have contributed to this discrepancy.
Finally, the intimate mechanisms of changes in protein immunoreactivity remain to be elucidated, but our results support the concept that the glucocorticoid dexamethasone has potential preventive effects on SAH-induced alterations in contractile and cytoskeletal proteins of the cerebral arteries. These preliminary results encourage additional studies of glucocorticoids that focus more precisely on post-SAH vasospasm.
